BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20961371)

  • 1. Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma.
    Wu JM; Skill NJ; Maluccio MA
    HPB (Oxford); 2010 Nov; 12(9):625-36. PubMed ID: 20961371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative Stress Attenuates Lipid Synthesis and Increases Mitochondrial Fatty Acid Oxidation in Hepatoma Cells Infected with Hepatitis C Virus.
    Douglas DN; Pu CH; Lewis JT; Bhat R; Anwar-Mohamed A; Logan M; Lund G; Addison WR; Lehner R; Kneteman NM
    J Biol Chem; 2016 Jan; 291(4):1974-1990. PubMed ID: 26627833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma.
    Smith MW; Yue ZN; Geiss GK; Sadovnikova NY; Carter VS; Boix L; Lazaro CA; Rosenberg GB; Bumgarner RE; Fausto N; Bruix J; Katze MG
    Cancer Res; 2003 Feb; 63(4):859-64. PubMed ID: 12591738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma.
    Tsuchiya M; Parker JS; Kono H; Matsuda M; Fujii H; Rusyn I
    Mol Cancer; 2010 Apr; 9():74. PubMed ID: 20380719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma.
    Ura S; Honda M; Yamashita T; Ueda T; Takatori H; Nishino R; Sunakozaka H; Sakai Y; Horimoto K; Kaneko S
    Hepatology; 2009 Apr; 49(4):1098-112. PubMed ID: 19173277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene profiling, biomarkers and pathways characterizing HCV-related hepatocellular carcinoma.
    De Giorgi V; Monaco A; Worchech A; Tornesello M; Izzo F; Buonaguro L; Marincola FM; Wang E; Buonaguro FM
    J Transl Med; 2009 Oct; 7():85. PubMed ID: 19821982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen.
    Lonardo A; Adinolfi LE; Restivo L; Ballestri S; Romagnoli D; Baldelli E; Nascimbeni F; Loria P
    World J Gastroenterol; 2014 Jun; 20(23):7089-103. PubMed ID: 24966582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ID2 associated with invasion of hepatitis C virus-related hepatocellular carcinoma by gene expression profile.
    Tsunedomi R; Iizuka N; Yamada-Okabe H; Tamesa T; Okada T; Sakamoto K; Takashima M; Hamaguchi T; Miyamoto T; Uchimura S; Hamamoto Y; Yamada M; Oka M
    Int J Oncol; 2006 Dec; 29(6):1445-51. PubMed ID: 17088983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma.
    Haberl EM; Weiss TS; Peschel G; Weigand K; Köhler N; Pauling JK; Wenzel JJ; Höring M; Krautbauer S; Liebisch G; Buechler C
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus.
    Zekri AR; Hassan ZK; Bahnassy AA; Sherif GM; ELdahshan D; Abouelhoda M; Ali A; Hafez MM
    Asian Pac J Cancer Prev; 2012; 13(11):5433-8. PubMed ID: 23317196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small heterodimer partner 1 directly interacts with NS5A viral protein and has a key role in HCV related liver cell transformation.
    Conti B; Porcu C; Viscomi C; Minutolo A; Costantini S; Corazzari M; Iannucci G; Barbaro B; Balsano C
    Oncotarget; 2016 Dec; 7(51):84575-84586. PubMed ID: 27661118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species.
    Fujinaga H; Tsutsumi T; Yotsuyanagi H; Moriya K; Koike K
    Oncology; 2011; 81 Suppl 1():11-7. PubMed ID: 22212930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.
    Koike K
    J Gastroenterol; 2009; 44 Suppl 19():82-8. PubMed ID: 19148799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis.
    Chang ML; Yeh CT; Chen JC; Huang CC; Lin SM; Sheen IS; Tai DI; Chu CM; Lin WP; Chang MY; Liang CK; Chiu CT; Lin DY
    BMC Genomics; 2008 Feb; 9():109. PubMed ID: 18307821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling.
    Ueda T; Honda M; Horimoto K; Aburatani S; Saito S; Yamashita T; Sakai Y; Nakamura M; Takatori H; Sunagozaka H; Kaneko S
    Genomics; 2013 Apr; 101(4):238-48. PubMed ID: 23485556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA expression profiles of hepatitis C virus-related dysplasia and hepatocellular carcinoma.
    Zhang H; Zhu C; Zhao Y; Li M; Wu L; Yang X; Wan X; Wang A; Zhang MQ; Sang X; Zhao H
    Oncotarget; 2015 Dec; 6(41):43770-8. PubMed ID: 26540467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
    Cheng Y; Ping J; Chen J
    Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.